Ignite Creation Date:
2024-05-06 @ 10:50 AM
Last Modification Date:
2024-10-26 @ 12:36 PM
Study NCT ID:
NCT03364348
Status:
COMPLETED
Last Update Posted:
2022-10-19
First Post:
2017-11-10
Brief Title:
4-1BB Agonist Monoclonal Antibody PF-05082566 With Trastuzumab Emtansine or Trastuzumab in Treating Patients With Advanced HER2-Positive Breast Cancer
Sponsor:
George W Sledge Jr
Organization:
Stanford University
Organization Data
Organization:
Stanford University
Class:
OTHER
Study ID:
IRB-37299
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
George W Sledge Jr
Lead Sponsor Class:
OTHER
Responsible Party:
George W Sledge Jr
Responsible Party Title:
Principal Investigator
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Stanford University
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |